Skip to main content

Table 2 Vertical gradient and heterogeneity in perfusion

From: Perfusion imaging heterogeneity during NO inhalation distinguishes pulmonary arterial hypertension (PAH) from healthy subjects and has potential as an imaging biomarker

Parameter

Control

PAH

Baseline

O2 + iNO

Baseline

O2 + iNO

Qvgrad (10–2 cm−1)

− 5.46 (− 3.32, − 7.01)*†

− 7.37 (−6.43, − 8.66)*‡

− 3.13 (− 2.33, − 4.78)†

− 2.51 (− 0.039, − 0.431)‡

CV2 Qtotal

0.09 (0.06, 0.16)

0.12 (0.08, 0.16)‡

0.08 (0.07, 0.11)

0.06 (0.04, 0.1)‡

CV2 Qvgrad

0.04 (0.02, 0.08)†

0.08 (0.055, 0.10)‡

0.01 (0.0, 0.03)†

0.01 (0.0002, 0.02)‡

CV2 Qr

0.04 (0.02, 0.07)

0.04 (0.02, 0.06)

0.05 (0.04, 0.06)

0.03 (0.02, 0.04)

  1. Continuous variables are represented as mean (min, max)
  2. PAH: primary pulmonary arterial hypertension; Qvgrad: vertical gradient in regional perfusion (slope); CV2Qtotal: squared coefficient of variation in perfusion quantifying total spatial heterogeneity of perfusion (noise corrected); CV2Qvgrad: squared coefficient of variation in perfusion quantifying heterogeneity generated by the dorsal–ventral gradient in perfusion; CV2Qr: squared coefficient of variation in perfusion quantifying heterogeneity of the residual perfusion
  3. *Significant difference between measures at baseline and during administration of O2 + iNO within a group
  4. †Significant difference between PAH subjects and controls at baseline
  5. ‡Significant difference between PAH subjects and controls while breathing O2 + iNO